UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Perioperative Lidocaine Infusions for the Management of Pain From Burn Injury

Phase 4

Not yet recruiting

Conditions: Pain Management
Burn Injury
Lidocaine

Interventions: Drug: IV Lidocaine
Drug: IV Saline

First Posted Date: 2025-02-14

Last Posted Date: 2025-04-04

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT06828601

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

Not Applicable

Recruiting

Conditions: Dementia, Mild
Mild Cognitive Impairment (MCI)

First Posted Date: 2025-02-10

Last Posted Date: 2025-03-25

Lead Sponsor: University of Washington

Target Recruit Count: 240

Registration Number: NCT06817122

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Comparison of Outcomes of Management of Bowel Obstruction Pilot Study

Phase 4

Conditions: Adhesive Small Bowel Obstruction

Interventions: Drug: Dexamethasone
Other: Supportive Care

First Posted Date: 2025-02-10

Last Posted Date: 2025-03-12

Lead Sponsor: University of Washington

Target Recruit Count: 10

Registration Number: NCT06817551

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Early BOTOX After Spinal Cord Injury

Early Phase 1

Conditions: Spinal Cord Injuries

Interventions: Drug: Bladder chemodenervation (Botox)
Procedure: Bladder Sham (Saline) Injection Procedure

First Posted Date: 2025-01-27

Last Posted Date: 2025-01-27

Lead Sponsor: University of Washington

Target Recruit Count: 10

Registration Number: NCT06793683

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Evaluation of Artificial Intelligence-Integrated Hearing Aids for Individuals with Hearing Loss

Not Applicable

Not yet recruiting

Conditions: Hearing Loss
Hearing Loss, Sensorineural

First Posted Date: 2025-01-24

Last Posted Date: 2025-01-24

Lead Sponsor: University of Washington

Target Recruit Count: 100

Registration Number: NCT06792110

Evaluation of an Asynchronous Remote Communities Approach to Behavioral Activation for Depressed Adolescents

Not Applicable

Not yet recruiting

Conditions: Depression
Adolescent Behavior

First Posted Date: 2025-01-22

Last Posted Date: 2025-01-22

Lead Sponsor: University of Washington

Target Recruit Count: 70

Registration Number: NCT06786247

Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

Phase 2

Not yet recruiting

Conditions: Recurrent Diffuse Large B-Cell Lymphoma
Recurrent Primary Mediastinal Large B-Cell Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Recurrent Grade 3b Follicular Lymphoma
Recurrent High Grade B-Cell Lymphoma
Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Refractory Grade 3b Follicular Lymphoma
Refractory High Grade B-Cell Lymphoma

Interventions: Biological: Odronextamab
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
Biological: Chimeric Antigen Receptor T-Cell Therapy
Procedure: Computed Tomography
Procedure: Leukapheresis
Procedure: Lumbar Puncture
Procedure: Positron Emission Tomography
Other: Questionnaire Administration
Procedure: Biopsy

First Posted Date: 2025-01-20

Last Posted Date: 2025-04-06

Lead Sponsor: University of Washington

Target Recruit Count: 27

Registration Number: NCT06784726

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation

Not Applicable

Recruiting

Conditions: Anatomic Stage 0 Breast Cancer AJCC v8
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Breast Carcinoma

First Posted Date: 2025-01-13

Last Posted Date: 2025-04-11

Lead Sponsor: University of Washington

Target Recruit Count: 30

Registration Number: NCT06772181

Locations: 🇺🇸
MultiCare Valley Hospital (Spokane), Spokane Valley, Washington, United States
🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data

Not Applicable

Recruiting

Conditions: Opioid Use Disorder
Opioid Use

First Posted Date: 2025-01-10

Last Posted Date: 2025-01-10

Lead Sponsor: University of Washington

Target Recruit Count: 40000

Registration Number: NCT06768814

Locations: 🇺🇸
Downtown Emergency Service Center's Overdose Recovery and Care Access Centers, Seattle, Washington, United States

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

Phase 2

Recruiting

Conditions: Advanced Hodgkin Lymphoma
Classic Hodgkin Lymphoma
Lugano Classification Stage III Hodgkin Lymphoma AJCC v8
Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8

Interventions: Procedure: Biospecimen Collection
Procedure: Computed Tomography
Drug: Dacarbazine
Drug: Doxorubicin
Procedure: Echocardiography
Procedure: Multigated Acquisition Scan
Biological: Nivolumab
Procedure: Positron Emission Tomography
Drug: Vinblastine
Other: Questionnaire

First Posted Date: 2024-12-20

Last Posted Date: 2025-03-10

Lead Sponsor: University of Washington

Target Recruit Count: 125

Registration Number: NCT06745076

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Home Terms & Conditions Privacy Policy